Alexandra de Sitter
Overview
Explore the profile of Alexandra de Sitter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Nieuwkerk A, Hemelrijk K, Aarts H, Leeuwis A, Majoie C, Daemen M, et al.
EClinicalMedicine
. 2025 Mar;
81:103092.
PMID: 40026830
Background: Approximately one-third of patients with symptomatic severe aortic valve stenosis scheduled for transcatheter aortic valve implantation (TAVI) have some degree of cognitive impairment. The effect of TAVI on cardiac...
2.
van Nieuwkerk A, Hemelrijk K, Bron E, Leeuwis A, Majoie C, Daemen M, et al.
Neth Heart J
. 2023 Nov;
31(12):461-470.
PMID: 37910335
Background: Approximately one-third of patients with symptomatic severe aortic valve stenosis who are scheduled for transcatheter aortic valve implantation (TAVI) have some degree of cognitive impairment. TAVI may have negative...
3.
Vrenken H, Jenkinson M, Pham D, Guttmann C, Pareto D, Paardekooper M, et al.
Neurology
. 2021 Oct;
97(21):989-999.
PMID: 34607924
Patients with multiple sclerosis (MS) have heterogeneous clinical presentations, symptoms, and progression over time, making MS difficult to assess and comprehend in vivo. The combination of large-scale data sharing and...
4.
de Sitter A, Burggraaff J, Bartel F, Palotai M, Liu Y, Simoes J, et al.
Neuroimage Clin
. 2021 Apr;
30:102659.
PMID: 33882422
Background: Deep grey matter (dGM) structures, particularly the thalamus, are clinically relevant in multiple sclerosis (MS). However, segmentation of dGM in MS is challenging; labeled MS-specific reference sets are needed...
5.
Burggraaff J, Liu Y, Prieto J, Simoes J, de Sitter A, Ruggieri S, et al.
Neuroimage Clin
. 2021 Jan;
29:102549.
PMID: 33401136
Background And Rationale: Thalamus atrophy has been linked to cognitive decline in multiple sclerosis (MS) using various segmentation methods. We investigated the consistency of the association between thalamus volume and...
6.
de Sitter A, Verhoeven T, Burggraaff J, Liu Y, Simoes J, Ruggieri S, et al.
J Neurol
. 2020 Jul;
267(12):3541-3554.
PMID: 32621103
Background: Deep grey matter (DGM) atrophy in multiple sclerosis (MS) and its relation to cognitive and clinical decline requires accurate measurements. MS pathology may deteriorate the performance of automated segmentation...
7.
Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Wheeler-Kingshott C, Calabrese M, et al.
Neuroimage Clin
. 2018 Jul;
19:466-475.
PMID: 29984155
Atrophy of the brain grey matter (GM) is an accepted and important feature of multiple sclerosis (MS). However, its accurate measurement is hampered by various technical, pathological and physiological factors....
8.
de Sitter A, Steenwijk M, Ruet A, Versteeg A, Liu Y, van Schijndel R, et al.
Neuroimage
. 2017 Sep;
163:106-114.
PMID: 28899746
Background And Purpose: In vivoidentification of white matter lesions plays a key-role in evaluation of patients with multiple sclerosis (MS). Automated lesion segmentation methods have been developed to substitute manual...
9.
Steenwijk M, Amiri H, Schoonheim M, de Sitter A, Barkhof F, Pouwels P, et al.
Neuroimage Clin
. 2017 Aug;
15:843-853.
PMID: 28794970
Introduction: Despite the recognized importance of atrophy in multiple sclerosis (MS), methods for its quantification have been mostly restricted to the research domain. Recently, a CE labelled and FDA approved...